stockrow
Saturday 7 November 2026
Export BTMD’s income statement to Excel — free account
biote Corp.
BTMD Healthcare Medical Care Facilities
biote Corp.’s revenue for fiscal 2025 (year ended December 2025) was $192.2 million, down 2.52% from fiscal 2024.
- Revenue
- −9.48%
- EPS
- −330.0%
- Free cash flow
- −174.2%
- Total debt
- +16.0%
Quarter to June 2026, against a year earlier
1.06
0.02
+1.92%
Follow BTMD
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Jun ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | 139 | 165 | 185 | 197 | 192 | 184 | +8.4% | 178 | 188 | 197 | +0.8% | |
| Gross margin, % | — | — | — | — | — | 64.98 | 66.92 | 68.78 | 70.52 | 71.46 | 68.58 | +6.5 pt | ||||||
| EBT | — | — | — | — | 0 | 33 | 2 | 0 | 1 | 38 | 10 | n/m | ||||||
| EBT margin, % | — | — | — | — | 0.00 | 23.61 | 1.04 | (0.07) | 0.52 | 19.55 | 5.59 | +19.6 pt | ||||||
| Net income | — | 0 | — | — | 0 | 33 | 1 | (3) | 0 | 32 | 7 | n/m | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | — | — | — | — | 0.00 | 18.40 | 20.47 | 7.21 | 5.75 | 6.14 | 6.41 | n/m | |||||
| Earnings | — | — | — | — | — | — | (0.12) | 0.13 | 0.09 | 0.86 | 0.16 | n/m | ||||||
| Cash flow | — | — | — | — | 0.00 | 4.45 | (1.14) | 1.05 | 1.32 | 1.13 | 0.85 | n/m | ||||||
| Capex | — | — | — | — | 0.00 | (0.50) | (0.23) | (0.11) | (0.20) | (0.22) | (0.24) | n/m | ||||||
| Free cash flow | — | — | — | — | 0.00 | 3.95 | (1.36) | 0.94 | 1.12 | 0.91 | 0.61 | n/m | ||||||
| Book value | — | — | — | — | 0.00 | 0.54 | (7.23) | (1.42) | (2.98) | (1.61) | (2.03) | n/m | ||||||
| Shares, m | — | — | — | — | 8 | 8 | 8 | 26 | 34 | 31 | 30 | +33.1% | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | 0.00 | 0.26 | 0.00 | 41.20 | 3.02 | 6.63 | 8.9 | |||||
| P/S | — | — | — | — | — | 0.00 | 0.18 | 0.66 | 1.07 | 0.42 | 0.17 | 0.5 | ||||||
| P/B | — | — | — | — | — | 18.68 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.7 | ||||||
| EV/Sales | — | — | — | — | — | 0.00 | 0.41 | 0.78 | 1.42 | 0.85 | 0.77 | 0.7 | ||||||
| EV/FCF | — | — | — | — | — | 2.92 | (6.20) | 6.02 | 7.31 | 5.80 | 8.03 | 3.2 | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | 0 | 34 | (9) | 27 | 45 | 35 | 24 | n/m | |||||
| Capex | — | — | — | — | — | (4) | (2) | (3) | (7) | (7) | (7) | +15.9% | ||||||
| Free cash flow | — | — | — | — | 0 | 30 | (11) | 24 | 38 | 28 | 18 | n/m | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | — | — | — | — | 0 | 30 | 82 | 100 | 17 | 10 | 13 | n/m | |||||
| Net debt | — | — | — | — | 0 | 10 | 39 | 24 | 68 | 83 | 110 | n/m | ||||||
| Shareholders’ equity | — | — | — | — | 0 | 4 | (58) | (37) | (102) | (50) | (58) | n/m | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | — | — | — | — | 0.00 | 119.75 | (1.17) | 2.48 | 2.27 | 23.52 | 5.67 | +23.5 pt | |||||
| ROIC | — | — | — | — | 0.00 | 150.82 | 0.00 | 0.00 | 0.00 | 68.34 | 17.68 | +68.3 pt | ||||||
| ROE | — | — | — | — | 0.00 | 1,572.00 | 3.58 | (6.99) | (4.55) | (35.45) | (8.55) | (35.4) pt | ||||||
| People | ||||||||||||||||||
| People | Employees | — | — | — | — | — | 4 | 186 | 194 | 217 | 223 | — | +173.3% | |||||
| Revenue/emp, $m | — | — | — | — | — | 34.85 | 0.89 | 0.96 | 0.91 | 0.86 | — | (60.3%) | ||||||
Negative figures in brackets.
estimates
Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 26 Oct 2026
biote Corp. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| JYNT The Joint Corp. | $104.2M | 25.5× | 20.1× | +14.41% (above 0%: growing) | +400.00% (above 0%: growing) | +432.31% (above 0%: growing) | 83.68% | (2.43%) | Compare |
| AIRS AirSculpt Technologies, Inc. | $103.8M | — (loss-making) | — (loss-making) | −8.71% (below 0%: shrinking) | n/m | −813.83% (below 0%: shrinking) | 0.00% | 0.00% | Compare |
| PARK Park Dental Partners, Inc. | $95.8M | — (loss-making) | — | +12.15% (above 0%: growing) | −65.84% (below 0%: shrinking) | −34.78% (below 0%: shrinking) | 14.37% | 1.90% | Compare |
| BMGL Basel Medical Group Ltd | $70.5M | — | — | — | — | — | — | — | Compare |
| CCEL Cryo-Cell International Inc. | $39.9M | — (loss-making) | 65.1× | −0.02% (below 0%: shrinking) | +77.78% (above 0%: growing) | −58.37% (below 0%: shrinking) | 79.38% | 28.04% | Compare |
| BTMD biote Corp. | $37.4M | 6.6× | — (loss-making) | −9.48% (below 0%: shrinking) | n/m | −174.16% (below 0%: shrinking) | 65.38% | (7.93%) | |
| PIII P3 Health Partners Inc. | $28.1M | — (loss-making) | — | +8.60% (above 0%: growing) | n/m | −272.24% (below 0%: shrinking) | 22.26% | 10.67% | Compare |
| DCGO DocGo Inc. | $24.1M | — (loss-making) | — (loss-making) | −8.70% (below 0%: shrinking) | n/m | −132.28% (below 0%: shrinking) | 30.52% | (24.41%) | Compare |
| CCM Concord Medical Services Holdings Limited | $10.0M | — (loss-making) | — (loss-making) | +37.65% (above 0%: growing) | n/m | −281.45% (below 0%: shrinking) | (13.15%) | 0.00% | Compare |
| Median of peers | $55.2M | — | — | +8.60% | +77.78% | −132.28% | 22.26% | 0.00% |
Pay and ownership Proxy statement filed 2 April 2026
Ownership
Directors and executive officers, together
32.40%
Teresa S. Weber
12.20%
Richard R. Barrera
12.20%
Entities affiliated with Roystone Capital Management LP
12.10%
Marc D. Beer
10.40%
325 Capital Entities
9.60%
Andrew R. Heyer
7.10%
Bandera Partners LLC
6.20%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more.
Read the proxy statement